137 related articles for article (PubMed ID: 20885451)
1. Lentiviral transfer of an inducible transgene expressing a soluble form of Gas1 causes glioma cell arrest, apoptosis and inhibits tumor growth.
López-Ornelas A; Mejía-Castillo T; Vergara P; Segovia J
Cancer Gene Ther; 2011 Feb; 18(2):87-99. PubMed ID: 20885451
[TBL] [Abstract][Full Text] [Related]
2. Targeted-simultaneous expression of Gas1 and p53 using a bicistronic adenoviral vector in gliomas.
Benítez JA; Arregui L; Vergara P; Segovia J
Cancer Gene Ther; 2007 Oct; 14(10):836-46. PubMed ID: 17599090
[TBL] [Abstract][Full Text] [Related]
3. Glial-specific retrovirally mediated gas1 gene expression induces glioma cell apoptosis and inhibits tumor growth in vivo.
Zamorano A; Mellström B; Vergara P; Naranjo JR; Segovia J
Neurobiol Dis; 2004 Apr; 15(3):483-91. PubMed ID: 15056455
[TBL] [Abstract][Full Text] [Related]
4. Neural stem cells producing an inducible and soluble form of Gas1 target and inhibit intracranial glioma growth.
López-Ornelas A; Vergara P; Segovia J
Cytotherapy; 2014 Jul; 16(7):1011-23. PubMed ID: 24529556
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
Zhang J; Frolov I; Russell SJ
J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
[TBL] [Abstract][Full Text] [Related]
6. Recombinant baculovirus containing the diphtheria toxin A gene for malignant glioma therapy.
Wang CY; Li F; Yang Y; Guo HY; Wu CX; Wang S
Cancer Res; 2006 Jun; 66(11):5798-806. PubMed ID: 16740719
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.
Allen C; McDonald C; Giannini C; Peng KW; Rosales G; Russell SJ; Galanis E
J Gene Med; 2004 Nov; 6(11):1216-27. PubMed ID: 15459967
[TBL] [Abstract][Full Text] [Related]
8. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
9. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.
Komata T; Kondo Y; Kanzawa T; Hirohata S; Koga S; Sumiyoshi H; Srinivasula SM; Barna BP; Germano IM; Takakura M; Inoue M; Alnemri ES; Shay JW; Kyo S; Kondo S
Cancer Res; 2001 Aug; 61(15):5796-802. PubMed ID: 11479218
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
[TBL] [Abstract][Full Text] [Related]
11. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.
Kaliberov S; Stackhouse MA; Kaliberova L; Zhou T; Buchsbaum DJ
Gene Ther; 2004 Apr; 11(8):658-67. PubMed ID: 14973547
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of vaccinia virus in glioma model.
Timiryasova TM; Li J; Chen B; Chong D; Langridge WH; Gridley DS; Fodor I
Oncol Res; 1999; 11(3):133-44. PubMed ID: 10527073
[TBL] [Abstract][Full Text] [Related]
13. Transcriptionally mediated gene targeting of gas1 to glioma cells elicits growth arrest and apoptosis.
Zamorano A; Lamas M; Vergara P; Naranjo JR; Segovia J
J Neurosci Res; 2003 Jan; 71(2):256-63. PubMed ID: 12503088
[TBL] [Abstract][Full Text] [Related]
14. A soluble form of GAS1 inhibits tumor growth and angiogenesis in a triple negative breast cancer model.
Jiménez A; López-Ornelas A; Estudillo E; González-Mariscal L; González RO; Segovia J
Exp Cell Res; 2014 Oct; 327(2):307-17. PubMed ID: 24992044
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas.
Corsten MF; Miranda R; Kasmieh R; Krichevsky AM; Weissleder R; Shah K
Cancer Res; 2007 Oct; 67(19):8994-9000. PubMed ID: 17908999
[TBL] [Abstract][Full Text] [Related]
16. Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors.
Indraccolo S; Habeler W; Tisato V; Stievano L; Piovan E; Tosello V; Esposito G; Wagner R; Uberla K; Chieco-Bianchi L; Amadori A
Cancer Res; 2002 Nov; 62(21):6099-107. PubMed ID: 12414634
[TBL] [Abstract][Full Text] [Related]
17. Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas.
Galanis E; Bateman A; Johnson K; Diaz RM; James CD; Vile R; Russell SJ
Hum Gene Ther; 2001 May; 12(7):811-21. PubMed ID: 11339897
[TBL] [Abstract][Full Text] [Related]
18. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector.
Rubinchik S; Yu H; Woraratanadharm J; Voelkel-Johnson C; Norris JS; Dong JY
Cancer Gene Ther; 2003 Nov; 10(11):814-22. PubMed ID: 14605667
[TBL] [Abstract][Full Text] [Related]
19. Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma.
Miletic H; Fischer YH; Giroglou T; Rueger MA; Winkeler A; Li H; Himmelreich U; Stenzel W; Jacobs AH; von Laer D
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6761-8. PubMed ID: 18006778
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]